Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/ Suction Devices), By End-use (Hospitals, Emergency Clinics), By Region, And Segment Forecasts, 2024 - 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,950	110 Pages	Grand View Research	November, 2023	GV18388578

Best Price Guarantee
Price	from $5,950
Length	110 Pages
Publisher	Grand View Research
Published Date	November, 2023
SKU	GV18388578

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/ Suction Devices), By End-use (Hospitals, Emergency Clinics), By Region, And Segment Forecasts, 2024 - 2030

Neurothrombectomy Devices Market Growth & Trends

The global neurothrombectomy devices market size is expected to reach USD 1.10 billion by 2030, growing at 6.87% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights

Based on products, clot retrievers segment dominated the market in 2023, with a share of 58.24% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players
Based on end-use, hospital segment dominated the market in 2023 with a share of 71.25% due to improving health care facilities and the availability of advanced equipment in the hospitals
Europe led the market with the maximum revenue share of 32.74% in 2023, owing to the increasing number of patients suffering from acute ischemic stroke in this region

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.1.1. Product; 1.1.2. End-use; 1.1.3. Regional scope; 1.1.4. Estimates and forecast timeline; 1.2. Research Methodology; 1.3. Information Procurement; 1.3.1. Purchased database; 1.3.2. GVR’s internal database; 1.3.3. Secondary sources; 1.3.4. Primary research; 1.3.5. Details of primary research; 1.3.5.1. Data for primary interviews in North America; 1.3.5.2. Data for primary interviews in Europe; 1.3.5.3. Data for primary interviews in Asia Pacific; 1.3.5.4. Data for primary interviews in Latin America; 1.3.5.5. Data for Primary interviews in MEA; 1.4. Information or Data Analysis; 1.4.1. Data analysis models; 1.5. Market Formulation & Validation; 1.6. Model Details; 1.6.1. Commodity flow analysis (Model 1); 1.6.1.1. Approach 1: Commodity flow approach; 1.6.2. Volume price analysis (Model 2); 1.6.2.1. Approach 2: Volume price analysis; 1.7. List of Secondary Sources; 1.8. List of Primary Sources; 1.9. Objectives; 1.9.1. Objective 1; 1.9.2. Objective 2
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Product outlook; 2.2.2. End-use outlook; 2.2.3. Regional outlook; 2.3. Competitive Insights
Chapter 3. Neurothrombectomy Devices Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent market outlook; 3.1.2. Related/ancillary market outlook; 3.2. Penetration & Growth Prospect Mapping; 3.3. Industry Value Chain Analysis; 3.3.1. Reimbursement framework; 3.4. Market Dynamics; 3.4.1. Market driver analysis; 3.4.1.1. Increasing prevalence of acute ischemic strokes; 3.4.1.2. Introduction of technologically advanced products; 3.4.1.3. Rising Adoption of unhealthy lifestyle; 3.4.2. Market restraint analysis; 3.4.2.1. Stringent and complex regulatory framework; 3.4.2.2. Risks associated with the neurothrombectomy devices; 3.5. Neurothrombectomy Devices Market Analysis Tools; 3.5.1. Industry Analysis - Porter’s; 3.5.1.1. Supplier power; 3.5.1.2. Buyer power; 3.5.1.3. Substitution threat; 3.5.1.4. The threat of new entrants; 3.5.1.5. Competitive rivalry; 3.5.2. PESTEL Analysis; 3.5.2.1. Political landscape; 3.5.2.2. Technological landscape; 3.5.2.3. Economic landscape; 3.5.3. Major Deals & Strategic Alliances Analysis; 3.5.4. Market Entry Strategies
Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis: 4.1. Definitions and Scope; 4.1.1. Clot Retrievers; 4.1.2. Aspiration/Suction Devices; 4.1.3. Vascular Snares; 4.2. Type Market Share, 2023 & 2030; 4.3. Segment Dashboard; 4.4. Neurothrombectomy Devices Market by Product Outlook; 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following; 4.5.1. Clot Retrievers; 4.5.1.1. Clot Retrievers market estimates and forecast 2018 to 2030 (USD Million); 4.5.2. Aspiration/Suction Devices; 4.5.2.1. Aspiration/Suction Devices market estimates and forecast 2018 to 2030 (USD Million); 4.5.3 Vascular Snares; 4.5.3.1 Vascular Snares market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Neurothrombectomy Devices Market: End-use Estimates & Trend Analysis: 5.1. Definitions and Scope; 5.1.1. Hospital; 5.1.2. Emergency Clinics; 5.1.3. Ambulatory Surgical Centers; 5.2. End-use Market Share, 2023 & 2030; 5.3. Segment Dashboard; 5.4. Neurothrombectomy Devices Market by End-use Outlook; 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following; 5.5.1. Hospital; 5.5.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million); 5.5.2. Emergency Clinics; 5.5.2.1. Emergency Clinics market estimates and forecast 2018 to 2030 (USD Million); 5.5.3. Ambulatory Surgical Centers; 5.5.3.1. Ambulatory Surgical Centers market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis: 6.1. Regional market share analysis, 2023 & 2030; 6.2. Regional Market Dashboard; 6.3. Global Regional Market Snapshot; 6.4. Regional Market Share and Leading Players, 2023; 6.4.1. North America; 6.4.2. Europe; 6.4.3. Asia Pacific; 6.4.4. Latin America; 6.4.5. Middle East and Africa; 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030; 6.6. North America; 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million); 6.6.2. U.S.; 6.6.2.1. Key country dynamics; 6.6.2.2. Competitive scenario; 6.6.2.3. Regulatory framework; 6.6.2.4. Reimbursement scenario; 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030; 6.6.3. Canada; 6.6.3.1. Key country dynamics; 6.6.3.2. Competitive scenario; 6.6.3.3. Regulatory framework; 6.6.3.4. Reimbursement scenario; 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030; 6.7. Europe; 6.7.1. UK; 6.7.1.1. Key country dynamics; 6.7.1.2. Competitive scenario; 6.7.1.3. Regulatory framework; 6.7.1.4. Reimbursement scenario; 6.7.1.5. UK market estimates and forecasts, 2018 - 2030; 6.7.2. Germany; 6.7.2.1. Key country dynamics; 6.7.2.2. Competitive scenario; 6.7.2.3. Regulatory framework; 6.7.2.4. Reimbursement scenario; 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030; 6.7.3. France; 6.7.3.1. Key country dynamics; 6.7.3.2. Competitive scenario; 6.7.3.3. Regulatory framework; 6.7.3.4. Reimbursement scenario; 6.7.3.5. France market estimates and forecasts, 2018 - 2030; 6.7.4. Italy; 6.7.4.1. Key country dynamics; 6.7.4.2. Competitive scenario; 6.7.4.3. Regulatory framework; 6.7.4.4. Reimbursement scenario; 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030; 6.7.5. Spain; 6.7.5.1. Key country dynamics; 6.7.5.2. Competitive scenario; 6.7.5.3. Regulatory framework; 6.7.5.4. Reimbursement scenario; 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030; 6.7.6. Denmark; 6.7.6.1. Key country dynamics; 6.7.6.2. Competitive scenario; 6.7.6.3. Regulatory framework; 6.7.6.4. Reimbursement scenario; 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030; 6.7.7. Sweden; 6.7.7.1. Key country dynamics; 6.7.7.2. Competitive scenario; 6.7.7.3. Regulatory framework; 6.7.7.4. Reimbursement scenario; 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030; 6.7.8. Norway; 6.7.8.1. Key country dynamics; 6.7.8.2. Competitive scenario; 6.7.8.3. Regulatory framework; 6.7.8.4. Reimbursement scenario; 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030; 6.8. Asia Pacific; 6.8.1. Japan; 6.8.1.1. Key country dynamics; 6.8.1.2. Competitive scenario; 6.8.1.3. Regulatory framework; 6.8.1.4. Reimbursement scenario; 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030; 6.8.2. India; 6.8.2.1. Key country dynamics; 6.8.2.2. Competitive scenario; 6.8.2.3. Regulatory framework; 6.8.2.4. Reimbursement scenario; 6.8.2.5. India market estimates and forecasts, 2018 - 2030; 6.8.3. China; 6.8.3.1. Key country dynamics; 6.8.3.2. Competitive scenario; 6.8.3.3. Regulatory framework; 6.8.3.4. Reimbursement scenario; 6.8.3.5. China market estimates and forecasts, 2018 - 2030; 6.8.4. South Korea; 6.8.4.1. Key country dynamics; 6.8.4.2. Competitive scenario; 6.8.4.3. Regulatory framework; 6.8.4.4. Reimbursement scenario; 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030; 6.8.5. Australia; 6.8.5.1. Key country dynamics; 6.8.5.2. Competitive scenario; 6.8.5.3. Regulatory framework; 6.8.5.4. Reimbursement scenario; 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030; 6.8.6. Thailand; 6.8.6.1. Key country dynamics; 6.8.6.2. Competitive scenario; 6.8.6.3. Regulatory framework; 6.8.6.4. Reimbursement scenario; 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030; 6.9. Latin America; 6.9.1. Brazil; 6.9.1.1. Key country dynamics; 6.9.1.2. Competitive scenario; 6.9.1.3. Regulatory framework; 6.9.1.4. Reimbursement scenario; 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030; 6.9.2. Mexico; 6.9.2.1. Key country dynamics; 6.9.2.2. Competitive scenario; 6.9.2.3. Regulatory framework; 6.9.2.4. Reimbursement scenario; 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030; 6.9.3. Argentina; 6.9.3.1. Key country dynamics; 6.9.3.2. Competitive scenario; 6.9.3.3. Regulatory framework; 6.9.3.4. Reimbursement scenario; 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030; 6.10. MEA; 6.10.1. South Africa; 6.10.1.1. Key country dynamics; 6.10.1.2. Competitive scenario; 6.10.1.3. Regulatory framework; 6.10.1.4. Reimbursement scenario; 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030; 6.10.2. Saudi Arabia; 6.10.2.1. Key country dynamics; 6.10.2.2. Competitive scenario; 6.10.2.3. Regulatory framework; 6.10.2.4. Reimbursement scenario; 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030; 6.10.3. UAE; 6.10.3.1. Key country dynamics; 6.10.3.2. Competitive scenario; 6.10.3.3. Regulatory framework; 6.10.3.4. Reimbursement scenario; 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030; 6.10.4. Kuwait; 6.10.4.1. Key country dynamics; 6.10.4.2. Competitive scenario; 6.10.4.3. Regulatory framework; 6.10.4.4. Reimbursement scenario; 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape: 7.1. Recent Developments & Impact Analysis, By Key Market Participants; 7.2. Company/Competition Categorization; 7.2.1. Innovators; 7.3. Vendor Landscape; 7.3.1. List of key distributors and channel partners; 7.3.2. Key customers; 7.3.3. Key company market share analysis, 2023; 7.3.4. Medtronic; 7.3.4.1. Company overview; 7.3.4.2. Financial performance; 7.3.4.3. Product benchmarking; 7.3.4.4. Strategic initiatives; 7.3.5. Acandis GmbH; 7.3.5.1. Company overview; 7.3.5.2. Financial performance; 7.3.5.3. Product benchmarking; 7.3.5.4. Strategic initiatives; 7.3.6. Phenox GmbH; 7.3.6.1. Company overview; 7.3.6.2. Financial performance; 7.3.6.3. Product benchmarking; 7.3.6.4. Strategic initiatives; 7.3.7. Stryker; 7.3.7.1. Company overview; 7.3.7.2. Financial performance; 7.3.7.3. Product benchmarking; 7.3.7.4. Strategic initiatives; 7.3.8. Penumbra, Inc.; 7.3.8.1. Company overview; 7.3.8.2. Financial performance; 7.3.8.3. Product benchmarking; 7.3.8.4. Strategic initiatives; 7.3.9. Vesalio; 7.3.9.1. Company overview; 7.3.9.2. Financial performance; 7.3.9.3. Product benchmarking; 7.3.9.4. Strategic initiatives

PDF E-mail From Publisher:	$5,950
Multi User License Fulfilled by Publisher:	$6,950
Global Site License Fulfilled by Publisher:	$8,950

Show additional purchase options...

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/ Suction Devices), By End-use (Hospitals, Emergency Clinics), By Region, And Segment Forecasts, 2024 - 2030

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/ Suction Devices), By End-use (Hospitals, Emergency Clinics), By Region, And Segment Forecasts, 2024 - 2030

Neurothrombectomy Devices Market Size, Trends, Analysis, and Outlook By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares), By End-user (Hospital, Emergency Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030

Neurothrombectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares); By End-Use; By Region; Segment Forecast, 2023 - 2032

Neurothrombectomy Devices Market Forecasts to 2030 – Global Analysis By Product (Clot Retrievers, Aspiration/Suction Devices and Vascular Snares), Type (Retriever, Integrated System and Other Types), Application and By Geography

Neurothrombectomy Devices Market by Product (Aspiration/Suction Devices, Clot Retrievers, Vascular Snares), Therapeutic Application (Arteriovenous Malformations (AVMs) & AV Fistulas, Cerebral Aneurysms, Cerebral Artery Stenosis), End-Use - Global Forecast

Neurothrombectomy Devices Market Size - By Product Type (Stent Retrievers, Aspiration Devices, Snares, Continuous Flush Catheter), End-use (Hospitals, Clinics, Ambulatory Surgical Centers) - Global Forecast (2024-2032)

Neurothrombectomy devices Market By Product Type (Clot Retrieval Devices, Aspiration Devices, Snares), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Research Assistance

Other tasks